{"rows":[{"id":2709,"title":"[Hallucinogens, amphetamines and entactogens].","authors":"Vollenweider FX, Vollenweider-Scherpenhuyzen MF","journal":"Therapeutische Umschau. Revue therapeutique","publication_date":"2003-06-01","publication_year":2003,"doi":"10.1024/0040-5930.60.6.323","pubmed_id":"12848067","openalex_id":"https://openalex.org/W2145879190","source_url":"https://pubmed.ncbi.nlm.nih.gov/12848067/","substance_tags":"psilocybin","topic_tags":"Emotional Processing,Observational Study,Safety,Toxicity","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:12848067","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/12848067/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:12848067","source_url":"https://pubmed.ncbi.nlm.nih.gov/12848067/","doi":"10.1024/0040-5930.60.6.323","pmid":"12848067","publication_date":"2003-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2644,"title":"[Mushroom poisoning--the dark side of mycetism].","authors":"Flammer R, Schenk-Jäger KM","journal":"Therapeutische Umschau. Revue therapeutique","publication_date":"2009-05-01","publication_year":2009,"doi":"10.1024/0040-5930.66.5.357","pubmed_id":"19401986","openalex_id":"https://openalex.org/W1971471676","source_url":"https://pubmed.ncbi.nlm.nih.gov/19401986/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:19401986","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/19401986/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:19401986","source_url":"https://pubmed.ncbi.nlm.nih.gov/19401986/","doi":"10.1024/0040-5930.66.5.357","pmid":"19401986","publication_date":"2009-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":285,"title":"[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].","authors":"Roser P","journal":"Therapeutische Umschau. Revue therapeutique","publication_date":"2026-02-01","publication_year":2026,"doi":"10.23785/tu.2026.01.006","pubmed_id":"41878754","openalex_id":"https://openalex.org/W7140918736","source_url":"https://pubmed.ncbi.nlm.nih.gov/41878754/","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41878754","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41878754/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41878754","source_url":"https://pubmed.ncbi.nlm.nih.gov/41878754/","doi":"10.23785/tu.2026.01.006","pmid":"41878754","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}}],"total":3,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Therapeutische Umschau. Revue therapeutique","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}